GRAIL, Inc. Common Stock (GRAL)
SERVICES-MEDICAL LABORATORIES
GRAIL, Inc. Common Stock (GRAL) is listed on Nasdaq, where it has traded since June 12, 2024.
- Listed On
- Nasdaq
- Listed Since
- June 12, 2024
- Employees
- 910
- Market Cap
- $5.7B
About GRAIL, Inc. Common Stock
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 364 institutions reported holding GRAL, with 38.0 million shares worth $2.6 billion in aggregate. The largest reported holder was Farallon Capital Management, with 4.2 million shares worth $284.1 million. Of the 5 largest holders listed below, 4 added shares and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Farallon Capital Management | 4,161,584 | $284M | Added 27.9% |
| Baker Bros. Advisors | 4,028,614 | $275M | Unchanged |
| BlackRock | 3,577,075 | $244M | Added 20.5% |
| Vanguard | 2,398,478 | $164M | Added 13.57% |
| State Street | 2,385,514 | $163M | Added 26.09% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is GRAL?
GRAIL, Inc. Common Stock (GRAL) is listed on Nasdaq, where it has traded since June 12, 2024.
Who are the largest institutional holders of GRAL?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of GRAL were Farallon Capital Management, Baker Bros. Advisors and BlackRock.
How many institutions own GRAL?
364 institutions reported a position in GRAL for the quarter ended June 30, 2026, worth $2.6 billion in total.
Did institutions buy or sell GRAL last quarter?
Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for GRAL.
Every reported institutional holder, plus insider and congressional trades in GRAL, on SentiSense.